Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Preventing POAF after heart surgery with posterior pericardiotomy

Official title: Pericardiotomy for Prevention of Postoperative Atrial Fibrillation After Cardiac Surgery in China

Run by Changhai Hospital · NCT06728826 · Data updated 2026-11-12

This trial tests whether posterior pericardiotomy during cardiac surgery can reduce new atrial fibrillation after surgery in adults in China.

More Atrial Fibrillation (AF) trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment650 (estimated)
SponsorChanghai Hospital
Academic / other
Locations1 site (Shanghai)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedDecember 31, 2026
Study endsJune 30, 2027
Registry record updatedJuly 14, 2026
Trial IDNCT06728826 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older undergoing surgery on proximal aorta, cardiac valves, or coronary arteries without a prior history of atrial fibrillation.

Probably not a fit

Patients with prior atrial fibrillation, certain complex procedures, or contraindications to pericardiotomy may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

PRINCE-CH is a multicenter randomized trial comparing posterior pericardiotomy to no posterior pericardiotomy in adults undergoing cardiac surgery in China. The primary outcome is the occurrence of postoperative atrial fibrillation, monitored with wearable ECG. The study aims to determine the safety and effectiveness of this surgical approach and its potential impact on recovery and resource use. Enrollment targets 650 participants across 15 centers, with continuous ECG monitoring during the postoperative period.

Why it matters

Potential benefit: If successful, patients may have a lower risk of POAF, potentially reducing complications and hospital stays.

How similar studies have gone: Earlier data suggest posterior pericardiotomy may reduce POAF, but definitive, long-term outcomes require this trial's results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients older than or equal to 18 years of age
* Requiring surgical intervention on proximal aorta, cardiac valves, and/or coronary arteries
* Able to provide informed consent

Exclusion Criteria:

* History of atrial fibrillation or flutter
* Reoperations/minimally invasive cardiac surgery/emergent presentation
* Need for hypothermic circulatory arrest
* Disease of the left pleura or previous left thoracotomy
* Chest deformity
* Unlikely to participate in follow-up assessments

Where it's running

  • Changhai Hospital
    Shanghai, China
    Recruiting

Study contacts

  • Principal investigator: Hao Zhang, M.D. Ph.D. — Naval Medical University Changhai Hospital
  • Study coordinator: Hao Zhang, M.D. Ph.D.
  • Email: 13818178916@163.com
  • Phone: 86-21-31161765

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.